Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Abbott Pinning Tricor Growth On Improved Formulation, Combination Use

Executive Summary

Abbott is hoping to build the lipid-lowering agent Tricor into a major global brand with the introduction of a new formulation and use as a combination therapy

You may also be interested in...



Abbott Considering Tricor/Statin Combination On Heels Of Labeling Change

Abbott is considering developing a Tricor/statin combination product, Pharmaceutical Product Group President Jeffrey Leiden said Jan. 18

Abbott Considering Tricor/Statin Combination On Heels Of Labeling Change

Abbott is considering developing a Tricor/statin combination product, Pharmaceutical Product Group President Jeffrey Leiden said Jan. 18

Reliant Will Add Antara, Omacor To Cardiovascular Product Line In 2005

Reliant will launch two recently-approved cardiovascular products, Antara and Omacor, in 2005

Related Content

UsernamePublicRestriction

Register

LL1132098

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel